The European Union and the UK-based pharmaceutical company AstraZeneca have settled their dispute over the company's failure to provide adequate coronavirus vaccines, with an agreement to extend it.
Speaking in Brussels today, AstraZeneca representative Ruud Dobber said his company was satisfied with its agreement with the European Commission, which will help deal with the COVID-19 disaster.
The European Commission was forced to go to court after the drug company failed to deliver 300 million doses of vaccine by the end of June this year, as promised.
Now AstraZeneca has been given until March next year to fulfill that number. European Union health commissioner Stella Kyriakides said today's agreement would secure the remaining 200 million doses of vaccines.
